S-Space

Browse

Author

Showing results 1 to 2 of 2

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2023-06	Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results. Meric-Bernstam, Funda; Makker, Vicky; Oaknin, Ana; Oh, Do Youn; Banerjee, Susana N.; Martin, Antonio Gonzalez; Jung, Kyung Hae; Lugowska, Iwona A.; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Anoka, Chiedozie; Ma, Yan; Puvvada, Soham D.; Lee, Jung-Yun Journal of Clinical Oncology, Vol.41 No.17_SUPPL, pp.LBA3000-LBA3000	DOI
2024-01	Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial Meric-Bernstam, Funda; Makker, Vicky; Oaknin, Ana; Oh, Do-Youn; Banerjee, Susana; González-Martín, Antonio; Jung, Kyung Hae; Ługowska, Iwona; Manso, Luis; Manzano, Aránzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Ma, Yan; Puvvada, Soham; Shire, Norah; Lee, Jung-Yun Journal of Clinical Oncology, Vol.42 No.1, pp.47-58	DOI